hotspot -WSS

hotspot

author：explore 2025-10-01 20:15:05 - browse：33186

Photo illustration of three children against a blue background. -- health coverage from STAT — The Pashai children (from left): Abubakar, Mohammad, and Sufyan. Illustration: STAT; Photo Courtesy

On a sweltering day in August 2021, as the engines of a hulking C-17 cargo plane drowned out pops of gunfire and Taliban rocket explosions around them, the young Afghan couple looked down at their 4-month-old son, Mohammad, and felt a shuddering wave of relief. But as the plane lifted above the dusty peaks that hug Kabul like a fortress of sandstone and schist, that feeling grew heavy with grief — for the parents and siblings they were leaving behind, and for Afghanistan, the only home they’d ever known. They did not know when, if ever, they would set foot there again.

Three years later, the Pashais are fearing for their family’s lives once again. This time the existential threat they face isn’t war, but a pair of faulty genes, silently passed down through their families for generations before detonating on American soil.

In October, Mohammad was diagnosed with a rare inherited disorder — metachromatic leukodystrophy. Genetic tests revealed his youngest brother, Sufyan, though he’s showing no symptoms, also has the disease. There’s a potential cure for Sufyan, a company offering it free of charge, and a team of doctors in Minnesota ready to administer it. But the Medicaid program in the Pashais’ new home state of Texas has said it won’t cover the cost of even an initial consult to confirm he’s a good candidate for the treatment.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Readout Newsletter: Amylyx, Aurinia, and IQVIA

Wikipedia

WSS

Long Covid research funding gets a major boost from NIH

Doctors on social media are being harassed and cyberbullied

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

White House finalizes ITC's import ban of latest Apple Watches

hotspot

hotspot

hotspot

ChatGPT in medicine: STAT answers readers' burning questions

Here’s what’s in the FDA plan to include pregnant women in clinical trials

DIEP, the 'gold standard' of breast reconstruction, is under threat

Congress might make insulin pumps more accessible to the blind

Medical records are filled with copy

3 medical device trends to watch in 2024

Novavax promises a turnaround & Lilly roils the obesity market

Study gives hint on South Asians’ higher risk of cardiovascular disease

Medical leaders decry Supreme Court decision on affirmative action

ACIP vaccine advisory panel sees its vacancies filled

hotspot

Videos point to link between seizures and unexplained toddler deaths

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

Juul documents reveal insider tactics on political lobbying

Tome Biosciences co

Websites selling Wegovy, Zepbound ingredients targeted by FDA

Goldman Sachs launches $650M fund for life science investments

entertainment

Wikipedia

focus

focus